Friday 5th April 2024 |
Text too small? |
The share price of BAI has risen from $0.017 on 2 April 2024 to $0.075 currently.
On 4 April 2024, NZ RegCo Surveillance issued an Issuer Price Enquiry to BAI asking it to confirm that it was not in possession of any material information which had not been disclosed to the market, and that it remained in compliance with the continuous disclosure provisions of the NZX Listing Rules. BAI confirmed that it remained in compliance with these listing rules.
BAI listed on 2 April 2024, following a reverse listing transaction. Under that transaction, the Being AI group of companies was acquired by Ascension Capital Limited (ACE) following shareholder approval on 28 March 2024.
The acquisition of the Being AI group of businesses was undertaken at a valuation equivalent to $0.025 per share.
The independent appraisal report published on that transaction concluded that, when the transaction was viewed as a whole, the terms and conditions of the transaction were fair to the independent ACE shareholders. NZ RegCo notes that assessment included the profile and valuation of the Being AI group businesses being acquired.
Investors are strongly urged to access and consider the information relevant to the recent reverse listing transaction of BAI, in support of any investment decisions. That information includes the listing profile of the Being AI Group, and the independent appraisal report. That information can be accessed at: https://www.nzx.com/companies/BAI/documents
ENDS
Being AI Limited – Trade with Caution statement
No comments yet
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report